Phase II trial of XmAb20717 (vudalimab) in patients with advanced biliary tract cancers

被引：0
|
作者：
Chapin, William Joseph [1 ]
Agarwal, Parul [1 ]
DiCicco, Lisa [1 ]
Palmer, Rayleigh [1 ]
Cenou, Nadia [1 ]
Huang, Alexander Chan Chi [1 ]
Karasic, Thomas Benjamin [1 ]
机构：
[1] Univ Penn, Abramson Canc Ctr, Philadelphia, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS4184
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A phase II trial of gemcitabine (G), cisplatin (C), and nab-paclitaxel (N) in advanced biliary tract cancers (aBTCs).
    Shroff, Rachna T.
    Borad, Mitesh J.
    Xiao, Lianchun
    Kaseb, Ahmed Omar
    Varadhachary, Gauri R.
    Wolff, Robert A.
    Raghav, Kanwal Pratap Singh
    Iwasaki, Michiko
    Masci, Peter
    Ramanathan, Ramesh K.
    Ahn, Daniel H.
    Bekaii-Saab, Tanios S.
    Javle, Milind M.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [22] A phase II trial of hepatic arterial infusion chemotherapy and bevacizumab in combination with toripalimab for advanced biliary tract cancers: Interim report
    Wang, X.
    Fu, S.
    Zheng, K.
    Cao, G.
    Xu, L.
    Yang, R.
    Zhu, X.
    Liu, P.
    Gao, S.
    Xu, H.
    Guo, J.
    Chen, H.
    Wang, K.
    Li, J.
    Zhou, J.
    Zhang, X.
    Hao, C.
    Xing, B.
    Shen, L.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S568 - S568
  • [23] Single-agent gemcitabine in the treatment of advanced biliary tract cancers: a phase II study
    Park, JS
    Oh, SY
    Kim, SH
    Kwon, HC
    Kim, JS
    Hyo, JK
    Kim, YH
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2005, 35 (02) : 68 - 73
  • [24] A phase II study of anlotinib with cediranib as a second-line treatment for patients with advanced biliary tract cancers (aBTCs).
    Zhao, Ruihua
    Zong, Hong
    Jin, Shuiling
    Zhong, Qian
    Jiang, Miao
    Jin, Ming
    Li, Rui
    Jiang, Guozhong
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [25] Combination Therapy of Gemcitabine and Irinotecan in Advanced Biliary Tract Cancer: Phase II Trial
    Chung, Moon Jae
    Park, Semi
    Park, Jeong Youp
    Bang, Seungmin
    Park, Seung Woo
    Song, Si Young
    GASTROENTEROLOGY, 2010, 138 (05) : S761 - S761
  • [26] Gemcitabine in advanced biliary tract cancers
    Pasetto, Lara Maria
    Andrea, Mario Rosario D'
    Falci, Cristina
    Monfardini, Silvio
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2007, 61 (03) : 230 - 242
  • [27] PHASE II TRIAL OF GEMCITABINE AND S-1 COMBINATION FOR PATIENTS WITH ADVANCED PANCREAS AND BILIARY TRACT CANCER
    Zang, D. Y.
    Kim, J. H.
    Hwang, S. W.
    Kim, H. Y.
    Kim, H. J.
    Song, H. H.
    Jung, J. Y.
    Kwon, J. H.
    Park, S.
    ANNALS OF ONCOLOGY, 2008, 19 : 185 - 185
  • [28] Immunotherapy in Advanced Biliary Tract Cancers
    Boileve, Alice
    Hilmi, Marc
    Smolenschi, Cristina
    Ducreux, Michel
    Hollebecque, Antoine
    Malka, David
    CANCERS, 2021, 13 (07)
  • [29] Preliminary safety and pharmacodynamic (PD) activity of XmAb20717, a PD-1 x CTLA-4 bispecific antibody, in a phase I dose escalation study of patients with selected advanced solid tumors.
    Hickingbottom, Barbara
    Clynes, Raphael
    Desjarlais, John
    Li, Caiyan
    Ding, Ying
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [30] Checkpoint inhibitors in patients with advanced, refractory biliary tract cancers
    Liddell, S.
    Wintheiser, G.
    Jin, Z.
    Tran, N.
    Mahipal, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S192 - S192
12345